Clinical Trial Update: Suvorexant to Reduce Symptoms of Nicotine Use [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating suvorexant for reducing nicotine withdrawal symptoms in adults seeking smoking cessation has completed, and results have been posted. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• Suvorexant (suvorexant)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2025-10-01